Answers are grounded in this paper and cite their sources.
NF1: historical background and introduction clinical and epidemiologic features evaluation and management genetics molecular biology and pathogenesis neurofibromas and malignanat peripheral nerve sheath tumours cognitive function and academic performance nervous system abnormalities optic pathway tumours other malignancies skeletal system vascular and endocrine abnormalities. NF2: clinial aspects associated tumours molecular biology. Appendix: resources for neurofibromatosis patients and their families.
No takes yet. Share an insight, caveat, or question.
Riccardi et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: